Clinical management of sleep disturbances in Alzheimer’s disease: current and emerging strategies

References

• HebertLEWeuveJScherrPAEvansDAAlzheimer disease in the United States (2010–2050) estimated using the 2010 censusNeurology201380191778178323390181
   PubMed Web of Science ®Google Scholar
• PistacchiMGioulisMContinFSansonFMarsalaSZSleep disturbance and cognitive disorder: epidemiological analysis in a cohort of 263 patientsNeurol Sci201435121955196225034185
   PubMed Web of Science ®Google Scholar
• MoranMLynchCAWalshCCoenRCoakleyDLawlorBASleep disturbance in mild to moderate Alzheimer’s diseaseSleep Med20056434735215978517
   PubMed Web of Science ®Google Scholar
• CiprianiGLucettiCDantiSNutiASleep disturbances and dementiaPsychogeriatrics2015151657425515641
   PubMed Web of Science ®Google Scholar
• VitielloMVBorsonSSleep disturbances in patients with Alzheimer’s disease: epidemiology, pathophysiology and treatmentCNS Drugs2001151077779611602004
   PubMed Web of Science ®Google Scholar
• HochCCReynoldsCF3rdKupferDJHouckPRBermanSRStackJASleep-disordered breathing in normal and pathologic agingJ Clin Psychiatry198647104995033759914
   PubMed Web of Science ®Google Scholar
• Ancoli-IsraelSKlauberMRButtersNParkerLKripkeDFDementia in institutionalized elderly: relation to sleep apneaJ Am Geriatr Soc19913932582632005339
   PubMed Web of Science ®Google Scholar
• ShinHYHanHJShinDJParkHMLeeYBParkKHSleep problems associated with behavioral and psychological symptoms as well as cognitive functions in Alzheimer’s diseaseJ Clin Neurol201410320320925045372
   PubMed Web of Science ®Google Scholar
• GauglerJEEdwardsABFemiaEEPredictors of institutionalization of cognitively impaired elders: family help and the timing of placementJ Gerontol B Psychol Sci Soc Sci2000554P247P25511584881
   PubMed Web of Science ®Google Scholar
• JuYELuceyBPHoltzmanDMSleep and Alzheimer disease pathology – a bidirectional relationshipNat Rev Neurol201410211511924366271
   PubMed Web of Science ®Google Scholar
• GuarnieriBSorbiSSleep and cognitive decline: a strong bidirectional relationship. It is time for specific recommendations on routine assessment and the management of sleep disorders in patients with mild cognitive impairment and dementiaEur Neurol2015741–2434826159605
   PubMed Web of Science ®Google Scholar
• VillaCFerini-StrambiLCombiRThe synergistic relationship between Alzheimer’s disease and sleep disorders: an updateJ Alzheimers Dis201546357158025835421
   PubMed Web of Science ®Google Scholar
• CookeJRAncoli-IsraelSNormal and abnormal sleep in the elderlyHandb Clin Neurol20119865366521056216
   PubMedGoogle Scholar
• Peter-DerexLYamminePBastujiHCroisileBSleep and Alzheimer’s diseaseSleep Med Rev201519293824846773
   PubMed Web of Science ®Google Scholar
• PrinzPNPeskindERVitalianoPPChanges in the sleep and waking EEGs of nondemented and demented elderly subjectsJ Am Geriatr Soc198230286937199061
   PubMed Web of Science ®Google Scholar
• PetitDGagnonJFFantiniMLFerini-StrambiLMontplaisirJSleep and quantitative EEG in neurodegenerative disordersJ Psychosom Res200456548749615172204
   PubMed Web of Science ®Google Scholar
• BornJRaschBGaisSSleep to rememberNeuroscientist200612541042416957003
   PubMed Web of Science ®Google Scholar
• DiekelmannSBornJThe memory function of sleepNat Rev Neurosci201011211412620046194
   PubMed Web of Science ®Google Scholar
• RauchsGSchabusMParapaticsSIs there a link between sleep changes and memory in Alzheimer’s disease?Neuroreport200819111159116218596620
   PubMed Web of Science ®Google Scholar
• RauchsGPiolinoPBertranFRetrieval of recent autobiographical memories is associated with slow-wave sleep in early ADFront Behav Neurosci2013711424065896
   PubMed Web of Science ®Google Scholar
• SongYDowlingGAWallhagenMILeeKAStrawbridgeWJSleep in older adults with Alzheimer’s diseaseJ Neurosci Nurs2010424190198 quiz 199–20020804113
   PubMed Web of Science ®Google Scholar
• BliwiseDLSleep disorders in Alzheimer’s disease and other dementiasClin Cornerstone20046Suppl 1AS16S2815259536
   PubMedGoogle Scholar
• KhachiyantsNTrinkleDSonSJKimKYSundown syndrome in persons with dementia: an updatePsychiatry Investig201184275287
   Web of Science ®Google Scholar
• CooganANSchutovaBHusungSThe circadian system in Alzheimer’s disease: disturbances, mechanisms, and opportunitiesBiol Psychiatry201374533333923273723
   PubMed Web of Science ®Google Scholar
• GnanasekaranG“Sundowning” as a biological phenomenon: current understandings and future directions: an updateAging Clin Exp Res Epub201585
   Web of Science ®Google Scholar
• FerrazzoliDSicaFSancesarioGSundowning syndrome: a possible marker of frailty in Alzheimer’s disease?CNS Neurol Disord Drug Targets201312452552823574165
   PubMed Web of Science ®Google Scholar
• GiubileiFPatacchioliFRAntoniniGAltered circadian cortisol secretion in Alzheimer’s disease: clinical and neuroradiological aspectsJ Neurosci Res200166226226511592122
   PubMed Web of Science ®Google Scholar
• HarperDGStopaEGMcKeeACDifferential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degenerationArch Gen Psychiatry200158435336011296096
   PubMed Web of Science ®Google Scholar
• VidenovicALazarASBarkerRAOvereemS“The clocks that time us” – circadian rhythms in neurodegenerative disordersNat Rev Neurol2014101268369325385339
   PubMed Web of Science ®Google Scholar
• StranahanAMChronobiological approaches to Alzheimer’s diseaseCurr Alzheimer Res201291939822329654
   PubMed Web of Science ®Google Scholar
• KadotaniHKadotaniTYoungTAssociation between apolipoprotein E epsilon4 and sleep-disordered breathing in adultsJAMA2001285222888289011401610
   PubMed Web of Science ®Google Scholar
• PanWKastinAJCan sleep apnea cause Alzheimer’s disease?Neurosci Biobehav Rev20144765666925451764
   PubMed Web of Science ®Google Scholar
• OsorioRSGumbTPirragliaESleep-disordered breathing advances cognitive decline in the elderlyNeurology201584191964197125878183
   PubMed Web of Science ®Google Scholar
• ReynoldsCF3rdKupferDJTaskaLSSleep apnea in Alzheimer’s dementia: correlation with mental deteriorationJ Clin Psychiatry19854672572614008448
   PubMed Web of Science ®Google Scholar
• CookeJRLiuLNatarajanLThe effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer’s diseaseBehav Sleep Med20064421922717083302
   PubMedGoogle Scholar
• YaffeKLaffanAMHarrisonSLSleep-disordered breathing, hypoxia, and risk of mild cognitive impairment and dementia in older womenJAMA2011306661361921828324
   PubMed Web of Science ®Google Scholar
• KielbSAAncoli-IsraelSRebokGWSpiraAPCognition in obstructive sleep apnea-hypopnea syndrome (OSAS): current clinical knowledge and the impact of treatmentNeuromolecular Med201214318019322569877
   PubMed Web of Science ®Google Scholar
• LalCStrangeCBachmanDNeurocognitive impairment in obstructive sleep apneaChest201214161601161022670023
   PubMed Web of Science ®Google Scholar
• BenedictCBybergLCedernaesJSelf-reported sleep disturbance is associated with Alzheimer’s disease risk in menAlzheimers Dement20151191090109725438949
   PubMed Web of Science ®Google Scholar
• JuYEMcLelandJSToedebuschCDSleep quality and preclinical Alzheimer diseaseJAMA Neurol201370558759323479184
   PubMed Web of Science ®Google Scholar
• LimASKowgierMYuLBuchmanASBennettDASleep fragmentation and the risk of incident Alzheimer’s disease and cognitive decline in older personsSleep20133671027103223814339
   PubMed Web of Science ®Google Scholar
• TranahGJBlackwellTStoneKLCircadian activity rhythms and risk of incident dementia and mild cognitive impairment in older womenAnn Neurol201170572273222162057
   PubMed Web of Science ®Google Scholar
• TsapanouAGuYO’SheaDDaytime somnolence as an early sign of cognitive decline in a community-based study of older peopleInt J Geriatr Psychiatry Epub2015615
   Web of Science ®Google Scholar
• SpiraAPChen-EdinboroLPWuMNYaffeKImpact of sleep on the risk of cognitive decline and dementiaCurr Opin Psychiatry201427647848325188896
   PubMed Web of Science ®Google Scholar
• HahnEAWangHXAndelRFratiglioniLA change in sleep pattern may predict Alzheimer diseaseAm J Geriatr Psychiatry201422111262127123954041
   PubMed Web of Science ®Google Scholar
• SpiraAPGamaldoAAAnYSelf-reported sleep and beta-amyloid deposition in community-dwelling older adultsJAMA Neurol201370121537154324145859
   PubMed Web of Science ®Google Scholar
• LimASYuLKowgierMSchneiderJABuchmanASBennettDAModification of the relationship of the apolipoprotein E epsilon4 allele to the risk of Alzheimer disease and neurofibrillary tangle density by sleepJAMA Neurol201370121544155124145819
   PubMed Web of Science ®Google Scholar
• HuangYPotterRSigurdsonWBeta-amyloid dynamics in human plasmaArch Neurol201269121591159723229043
   PubMedGoogle Scholar
• MusiekESXiongDDHoltzmanDMSleep, circadian rhythms, and the pathogenesis of Alzheimer diseaseExp Mol Med201547e14825766617
   PubMed Web of Science ®Google Scholar
• SlatsDClaassenJAVerbeekMMOvereemSReciprocal interactions between sleep, circadian rhythms and Alzheimer’s disease: focus on the role of hypocretin and melatoninAgeing Res Rev201312118820022575905
   PubMed Web of Science ®Google Scholar
• de LeceaLKilduffTSPeyronCThe hypocretins: hypothalamus-specific peptides with neuroexcitatory activityProc Natl Acad Sci U S A19989513223279419374
   PubMed Web of Science ®Google Scholar
• PeyronCTigheDKvan den PolANNeurons containing hypocretin (orexin) project to multiple neuronal systemsJ Neurosci199818239996100159822755
   PubMed Web of Science ®Google Scholar
• MiedaMTsujinoNSakuraiTDifferential roles of orexin receptors in the regulation of sleep/wakefulnessFront Endocrinol (Lausanne)201345723730297
   PubMedGoogle Scholar
• TsujinoNSakuraiTRole of orexin in modulating arousal, feeding, and motivationFront Behav Neurosci201372823616752
   PubMed Web of Science ®Google Scholar
• KangJELimMMBatemanRJAmyloid-beta dynamics are regulated by orexin and the sleep-wake cycleScience200932659551005100719779148
   PubMed Web of Science ®Google Scholar
• FronczekRvan GeestSFrolichMHypocretin (orexin) loss in Alzheimer’s diseaseNeurobiol Aging20123381642165021546124
   PubMed Web of Science ®Google Scholar
• RipleyBOvereemSFujikiNCSF hypocretin/orexin levels in narcolepsy and other neurological conditionsNeurology200157122253225811756606
   PubMed Web of Science ®Google Scholar
• DauvilliersYBaumannCRCarlanderBCSF hypocretin-1 levels in narcolepsy, kleine-levin syndrome, and other hypersomnias and neurological conditionsJ Neurol Neurosurg Psychiatry200374121667167314638887
   PubMed Web of Science ®Google Scholar
• DeuschleMSchillingCLewekeFMHypocretin in cerebrospinal fluid is positively correlated with tau and pTauNeurosci Lett2014561414524373987
   PubMed Web of Science ®Google Scholar
• SchmidtFMKratzschJGertzHJCerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer’s diseasePLoS One201385e6313623667582
   PubMed Web of Science ®Google Scholar
• WennstromMLondosEMinthonLNielsenHMAltered CSF orexin and alpha-synuclein levels in dementia patientsJ Alzheimers Dis201229112513222207004
   PubMed Web of Science ®Google Scholar
• SlatsDClaassenJALammersGJMelisRJVerbeekMMOvereemSAssociation between hypocretin-1 and amyloid-beta42 cerebrospinal fluid levels in Alzheimer’s disease and healthy controlsCurr Alzheimer Res20129101119112522742854
   PubMed Web of Science ®Google Scholar
• DauvilliersYALehmannSJaussentIGabelleAHypocretin and brain beta-amyloid peptide interactions in cognitive disorders and narcolepsyFront Aging Neurosci2014611924966833
   PubMed Web of Science ®Google Scholar
• ClaustratBLestonJMelatonin: physiological effects in humansNeurochirurgie2015612–3778425908646
   PubMed Web of Science ®Google Scholar
• MishimaKTozawaTSatohKMatsumotoYHishikawaYOkawaMMelatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-wakingBiol Psychiatry199945441742110071710
   PubMed Web of Science ®Google Scholar
• WuYHSwaabDFThe human pineal gland and melatonin in aging and Alzheimer’s diseaseJ Pineal Res200538314515215725334
   PubMed Web of Science ®Google Scholar
• ZhouJNLiuRYKamphorstWHofmanMASwaabDFEarly neuropathological Alzheimer’s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levelsJ Pineal Res200335212513012887656
   PubMed Web of Science ®Google Scholar
• WuYHFischerDFKalsbeekAPineal clock gene oscillation is disturbed in Alzheimer’s disease, due to functional disconnection from the “master clock.”FASEB J200620111874187616818472
   PubMed Web of Science ®Google Scholar
• LiuRYZhouJNvan HeerikhuizeJHofmanMASwaabDFDecreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer’s disease, and apolipoprotein E-epsilon4/4 genotypeJ Clin Endocrinol Metab19998413233279920102
   PubMed Web of Science ®Google Scholar
• Hita-YanezEAtienzaMCanteroJLPolysomnographic and subjective sleep markers of mild cognitive impairmentSleep20133691327133423997365
   PubMed Web of Science ®Google Scholar
• GottliebDJDeStefanoALFoleyDJAPOE epsilon4 is associated with obstructive sleep apnea/hypopnea: the sleep heart health studyNeurology200463466466815326239
   PubMed Web of Science ®Google Scholar
• LinLHuangQXYangSSChuJWangJZTianQMelatonin in Alzheimer’s diseaseInt J Mol Sci2013147145751459323857055
   PubMed Web of Science ®Google Scholar
• RoseKMBeckCTsaiPFSleep disturbances and nocturnal agitation behaviors in older adults with dementiaSleep201134677978621629366
   PubMed Web of Science ®Google Scholar
• AllenRPKushidaCAAtkinsonMJRLS QoL ConsortiumFactor analysis of the international restless legs syndrome study group’s scale for restless legs severitySleep Med20034213313514592343
   PubMed Web of Science ®Google Scholar
• GuarnieriBAdorniFMusiccoMPrevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patientsDement Geriatr Cogn Disord2012331505822415141
   PubMed Web of Science ®Google Scholar
• TalaricoGCanevelliMTostoGRestless legs syndrome in a group of patients with Alzheimer’s diseaseAm J Alzheimers Dis Other Demen201328216517023264651
   PubMed Web of Science ®Google Scholar
• RedekerNSSteinSCharacteristics of sleep in patients with stable heart failure versus a comparison groupHeart Lung200635425226116863897
   PubMed Web of Science ®Google Scholar
• DignaniLToccaceliALucertiniCPetrucciCLanciaLSleep and quality of life in people with COPD: a descriptive-correlational studyClin Nurs Res Epub201564
   Web of Science ®Google Scholar
• Geiger-BrownJLindbergSKrachmanSSelf-reported sleep quality and acute exacerbations of chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis20151038939725759571
   PubMed Web of Science ®Google Scholar
• KatzPMargarettenMTrupinLSchmajukGYazdanyJYelinESleep disturbance, depression, obesity, and physical inactivity explain a significant portion of fatigue in rheumatoid arthritisArthritis Care Res (Hoboken) Epub2015316
   Web of Science ®Google Scholar
• FujiwaraYArakawaTFassRGastroesophageal reflux disease and sleepGastroenterol Clin North Am2013421577023452631
   PubMed Web of Science ®Google Scholar
• BliwiseDLRosenRCBaumNImpact of nocturia on sleep and quality of life: a brief, selected review for the international consultation on incontinence research society (ICI-RS) nocturia think tankNeurourol Urodyn201433Suppl 1S15S1824729148
   PubMed Web of Science ®Google Scholar
• MigliorelliRTesonASabeLPetracchiMLeiguardaRStarksteinSEPrevalence and correlates of dysthymia and major depression among patients with Alzheimer’s diseaseAm J Psychiatry1995152137447802118
   PubMed Web of Science ®Google Scholar
• ForalPKnezevichJDewanNMaleskerMMedication-induced sleep disturbancesConsult Pharm201126641442521628140
   PubMedGoogle Scholar
• MostEIAboudanSScheltensPVan SomerenEJDiscrepancy between subjective and objective sleep disturbances in early- and moderate-stage Alzheimer diseaseAm J Geriatr Psychiatry201220646046722531105
   PubMed Web of Science ®Google Scholar
• TractenbergRESingerCMCummingsJLThalLJThe sleep disorders inventory: an instrument for studies of sleep disturbance in persons with Alzheimer’s diseaseJ Sleep Res200312433133714633245
   PubMed Web of Science ®Google Scholar
• YesavageJAFriedmanLAncoli-IsraelSDevelopment of diagnostic criteria for defining sleep disturbance in Alzheimer’s diseaseJ Geriatr Psychiatry Neurol200316313113912967054
   PubMed Web of Science ®Google Scholar
• Van de WaterATHolmesAHurleyDAObjective measurements of sleep for non-laboratory settings as alternatives to polysomnography – a systematic reviewJ Sleep Res2011201 Pt 218320020374444
   PubMed Web of Science ®Google Scholar
• Ancoli-IsraelSCloptonPKlauberMRFellRMasonWUse of wrist activity for monitoring sleep/wake in demented nursing-home patientsSleep199720124279130330
   PubMed Web of Science ®Google Scholar
• BrownCABerryRTanMCKhoshiaATurlapatiLSwedloveFA critique of the evidence base for non-pharmacological sleep interventions for persons with dementiaDementia (London)201312221023724336770
   PubMedGoogle Scholar
• AlessiCAYoonEJSchnelleJFAl-SamarraiNRCruisePAA randomized trial of a combined physical activity and environmental intervention in nursing home residents: do sleep and agitation improve?J Am Geriatr Soc199947778479110404920
   PubMed Web of Science ®Google Scholar
• GitlinLNKalesHCLyketsosCGNonpharmacologic management of behavioral symptoms in dementiaJAMA2012308192020202923168825
   PubMed Web of Science ®Google Scholar
• McCurrySMPikeKCVitielloMVLogsdonRGLarsonEBTeriLIncreasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer’s disease: results of a randomized, controlled trialJ Am Geriatr Soc20115981393140221797835
   PubMed Web of Science ®Google Scholar
• DeschenesCLMcCurrySMCurrent treatments for sleep disturbances in individuals with dementiaCurr Psychiatry Rep2009111202619187704
   PubMed Web of Science ®Google Scholar
• ShubDDarvishiRKunikMENon-pharmacologic treatment of insomnia in persons with dementiaGeriatrics2009642222619256583
   PubMed Web of Science ®Google Scholar
• MishimaKOkawaMHishikawaYHozumiSHoriHTakahashiKMorning bright light therapy for sleep and behavior disorders in elderly patients with dementiaActa Psychiatr Scand1994891178140901
   PubMed Web of Science ®Google Scholar
• Van SomerenEJKesslerAMirmiranMSwaabDFIndirect bright light improves circadian rest-activity rhythm disturbances in demented patientsBiol Psychiatry19974199559639110101
   PubMed Web of Science ®Google Scholar
• ItoTYamaderaHItoREndoSEffects of bright light on cognitive disturbances in Alzheimer-type dementiaNihon Ika Daigaku Zasshi199966422923810466338
   PubMedGoogle Scholar
• YamaderaHItoTSuzukiHAsayamaKItoREndoSEffects of bright light on cognitive and sleep-wake (circadian) rhythm disturbances in Alzheimer-type dementiaPsychiatry Clin Neurosci200054335235311186110
   PubMed Web of Science ®Google Scholar
• GrafAWallnerCSchubertVThe effects of light therapy on mini-mental state examination scores in demented patientsBiol Psychiatry200150972572711704081
   PubMed Web of Science ®Google Scholar
• Riemersma-van der LekRFSwaabDFTwiskJHolEMHoogendijkWJVan SomerenEJEffect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trialJAMA2008299222642265518544724
   PubMed Web of Science ®Google Scholar
• Ancoli-IsraelSGehrmanPMartinJLIncreased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer’s disease patientsBehav Sleep Med200311223615600135
   PubMedGoogle Scholar
• DowlingGAHubbardEMMastickJLuxenbergJSBurrRLVan SomerenEJEffect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer’s diseaseInt Psychogeriatr200517222123616050432
   PubMed Web of Science ®Google Scholar
• DowlingGABurrRLVan SomerenEJMelatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer’s diseaseJ Am Geriatr Soc200856223924618070004
   PubMed Web of Science ®Google Scholar
• BurnsAAllenHTomensonBDuignanDByrneJBright light therapy for agitation in dementia: a randomized controlled trialInt Psychogeriatr200921471172119323872
   PubMed Web of Science ®Google Scholar
• FigueiroMGPlitnickBALokATailored lighting intervention improves measures of sleep, depression, and agitation in persons with Alzheimer’s disease and related dementia living in long-term care facilitiesClin Interv Aging201491527153725246779
   PubMed Web of Science ®Google Scholar
• HanfordNFigueiroMLight therapy and Alzheimer’s disease and related dementia: Past, present, and futureJ Alzheimers Dis201333491392223099814
   PubMed Web of Science ®Google Scholar
• ForbesDBlakeCMThiessenEJPeacockSHawranikPLight therapy for improving cognition, activities of daily living, sleep, challenging behaviour, and psychiatric disturbances in dementiaCochrane Database Syst Rev20142CD00394624574061
   PubMed Web of Science ®Google Scholar
• Fontana GasioPKrauchiKCajochenCDawn-dusk simulation light therapy of disturbed circadian rest-activity cycles in demented elderlyExp Gerontol2003381–220721612543279
   PubMed Web of Science ®Google Scholar
• Ancoli-IsraelSMartinJLGehrmanPEffect of light on agitation in institutionalized patients with severe Alzheimer diseaseAm J Geriatr Psychiatry200311219420312611749
   PubMed Web of Science ®Google Scholar
• DowlingGAGrafCLHubbardEMLuxenbergJSLight treatment for neuropsychiatric behaviors in Alzheimer’s diseaseWest J Nurs Res200729896197517596638
   PubMed Web of Science ®Google Scholar
• NowakLThe effect of timed blue-green light on sleep-wake patterns in women with Alzheimer’ diseaseDissertation Abstracts Int Sect B Theses Sci Eng2008696-B
   Google Scholar
• McCleeryJCohenDASharpleyALPharmacotherapies for sleep disturbances in Alzheimer’s diseaseCochrane Database Syst Rev20143CD00917824659320
   PubMed Web of Science ®Google Scholar
• NeubauerDNChronic insomniaContinuum (Minneap Minn)2013191 Sleep Disorders506623385694
   PubMedGoogle Scholar
• CardinaliDPFurioAMReyesMPClinical perspectives for the use of melatonin as a chronobiotic and cytoprotective agentAnn N Y Acad Sci2005105732733616399904
   PubMed Web of Science ®Google Scholar
• PolimeniGEspositoEBevelacquaVGuarneriCCuzzocreaSRole of melatonin supplementation in neurodegenerative disordersFront Biosci (Landmark Ed)20141942944624389194
   PubMed Web of Science ®Google Scholar
• Di DomenicoFBaroneEPerluigiMButterfieldDAStrategy to reduce free radical species in Alzheimer’s disease: an update of selected antioxidantsExpert Rev Neurother2015151194025243342
   PubMed Web of Science ®Google Scholar
• AsayamaKYamaderaHItoTSuzukiHKudoYEndoSDouble blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementiaJ Nippon Med Sch200370433434112928714
   PubMedGoogle Scholar
• GehrmanPRConnorDJMartinJLShochatTCorey-BloomJAncoli-IsraelSMelatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer diseaseAm J Geriatr Psychiatry200917216616919155748
   PubMed Web of Science ®Google Scholar
• SingerCTractenbergREKayeJA multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s diseaseSleep200326789390114655926
   PubMed Web of Science ®Google Scholar
• SerfatyMKennell-WebbSWarnerJBlizardRRavenPDouble blind randomised placebo controlled trial of low dose melatonin for sleep disorders in dementiaInt J Geriatr Psychiatry200217121120112712461760
   PubMed Web of Science ®Google Scholar
• MahlbergRWaltherSActigraphy in agitated patients with dementia. monitoring treatment outcomesZ Gerontol Geriatr200740317818417565435
   PubMed Web of Science ®Google Scholar
• WadeAGFarmerMHarariGAdd-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer’s disease: a 6-month, randomized, placebo-controlled, multicenter trialClin Interv Aging2014994796124971004
   PubMed Web of Science ®Google Scholar
• DuboisBAlbertMLAmnestic MCI or prodromal Alzheimer’s disease?Lancet Neurol20043424624815039037
   PubMed Web of Science ®Google Scholar
• FurioAMBruscoLICardinaliDPPossible therapeutic value of melatonin in mild cognitive impairment: a retrospective studyJ Pineal Res200743440440917910609
   PubMed Web of Science ®Google Scholar
• CardinaliDPVigoDEOlivarNVidalMFFurioAMBruscoLITherapeutic application of melatonin in mild cognitive impairmentAm J Neurodegener Dis20121328029123383398
   PubMedGoogle Scholar
• VermeerenACoenenAMEffects of the use of hypnotics on cognitionProg Brain Res20111908910321531246
   PubMed Web of Science ®Google Scholar
• Billioti de GageSMorideYDucruetTBenzodiazepine use and risk of Alzheimer’s disease: case-control studyBMJ2014349g520525208536
   PubMed Web of Science ®Google Scholar
• DefrancescoMMarksteinerJFleischhackerWWBlaskoIUse of benzodiazepines in Alzheimer’s disease: a systematic review of literatureInt J Neuropsychopharmacol20151810pyv05525991652
   PubMed Web of Science ®Google Scholar
• RosenbergPBBenzodiazepine exposure increases risk of Alzheimer’s diseaseEvid Based Med2015202110117
   Google Scholar
• WuCSWangSCChangISLinKMThe association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims dataAm J Geriatr Psychiatry200917761462019546656
   PubMed Web of Science ®Google Scholar
• ZhangYZhouXHMeranusDHWangLKukullWABenzodiazepine use and cognitive decline in elderly with normal cognitionAlzheimer Dis Assoc Disord Epub201565
   Web of Science ®Google Scholar
• OtmaniSDemazieresAStanerCEffects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteersHum Psychopharmacol200823869370518763235
   PubMed Web of Science ®Google Scholar
• BeckerPMSomiahMNon-benzodiazepine receptor agonists for insomniaSleep Med Clin2015101577626055674
   PubMedGoogle Scholar
• ShihHILinCCTuYFAn increased risk of reversible dementia may occur after zolpidem derivative use in the elderly population: a population-based case-control studyMedicine (Baltimore)20159417e80925929937
   PubMed Web of Science ®Google Scholar
• RajiMABradySRMirtazapine for treatment of depression and comorbidities in Alzheimer diseaseAnn Pharmacother20013591024102711573849
   PubMed Web of Science ®Google Scholar
• BanerjeeSHellierJDeweyMSertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trialLancet2011378978940341121764118
   PubMed Web of Science ®Google Scholar
• MendelsonWBA review of the evidence for the efficacy and safety of trazodone in insomniaJ Clin Psychiatry200566446947615816789
   PubMed Web of Science ®Google Scholar
• CamargosEFLouzadaLLQuintasJLNavesJOLouzadaFMNobregaOTTrazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled studyAm J Geriatr Psychiatry201422121565157424495406
   PubMed Web of Science ®Google Scholar
• MaustDTKimHMSeyfriedLSAntipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harmJAMA Psychiatry201572543844525786075
   PubMed Web of Science ®Google Scholar
• TanLTanLWangHFEfficacy and safety of atypical antipsychotic drug treatment for dementia: a systematic review and meta-analysisAlzheimers Res Ther20157120 eCollection 201525897331
   PubMed Web of Science ®Google Scholar
• Wirz-JusticeAWerthESavaskanEKnoblauchVGasioPFMuller-SpahnFHaloperidol disrupts, clozapine reinstates the circadian rest-activity cycle in a patient with early-onset Alzheimer diseaseAlzheimer Dis Assoc Disord200014421221511186599
   PubMed Web of Science ®Google Scholar
• LippmannSMazourIShahabHInsomnia: therapeutic approachSouth Med J200194986687311592743
   PubMed Web of Science ®Google Scholar
• CookeJRLoredoJSLiuLAcetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer’s diseaseDrugs Aging200623650351116872233
   PubMed Web of Science ®Google Scholar
• Moraes WdosSPoyaresDRGuilleminaultCRamosLRBertolucciPHTufikSThe effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled studySleep200629219920516494088
   PubMed Web of Science ®Google Scholar
• SchredlMHornungORegenFAlbrechtNDanker-HopfeHHeuserIThe effect of donepezil on sleep in elderly, healthy persons: a double-blind placebo-controlled studyPharmacopsychiatry200639620520817124641
   PubMed Web of Science ®Google Scholar
• SongHRWooYSWangHRJunTYBahkWMEffect of the timing of acetylcholinesterase inhibitor ingestion on sleepInt Clin Psychopharmacol201328634634823948729
   PubMed Web of Science ®Google Scholar
• KitabayashiYUedaHTsuchidaHYamashitaTNarumotoJFukuiKDonepezil-induced nightmares in mild cognitive impairmentPsychiatry Clin Neurosci200660112312416472374
   PubMed Web of Science ®Google Scholar
• NaharciMIOzturkAYasarHGalantamine improves sleep quality in patients with dementiaActa Neurol Belg2015115456356825777522
   PubMed Web of Science ®Google Scholar
• Ancoli-IsraelSAmatniekJAscherSSadikKRamaswamyKEffects of galantamine versus donepezil on sleep in patients with mild to moderate Alzheimer disease and their caregivers: a double-blind, head-to-head, randomized pilot studyAlzheimer Dis Assoc Disord200519424024516327351
   PubMed Web of Science ®Google Scholar
• KauferDIBorsonSKershawPSadikKReduction of caregiver burden in Alzheimer’s disease by treatment with galantamineCNS Spectr200510648148815908902
   PubMed Web of Science ®Google Scholar
• YehSBYehPYSchenckCHRivastigmine-induced REM sleep behavior disorder (RBD) in a 88-year-old man with Alzheimer’s diseaseJ Clin Sleep Med20106219219520411699
   PubMed Web of Science ®Google Scholar
• RingmanJMSimmonsJHTreatment of REM sleep behavior disorder with donepezil: a report of three casesNeurology200055687087110994012
   PubMed Web of Science ®Google Scholar
• BrunettiVLosurdoATestaniERivastigmine for refractory REM behavior disorder in mild cognitive impairmentCurr Alzheimer Res201411326727324597506
   PubMed Web of Science ®Google Scholar
• VermaARadtkeRAVanLandinghamKEKingJHHusainAMSlow wave sleep rebound and REM rebound following the first night of treatment with CPAP for sleep apnea: correlation with subjective improvement in sleep qualitySleep Med20012321522311311684
   PubMed Web of Science ®Google Scholar
• ChongMSAyalonLMarlerMContinuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer’s disease with sleep disordered breathingJ Am Geriatr Soc200654577778116696743
   PubMed Web of Science ®Google Scholar
• Ancoli-IsraelSPalmerBWCookeJRCognitive effects of treating obstructive sleep apnea in Alzheimer’s disease: a randomized controlled studyJ Am Geriatr Soc200856112076208118795985
   PubMed Web of Science ®Google Scholar
• MoraesWPoyaresDSukys-ClaudinoLGuilleminaultCTufikSDonepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled studyChest2008133367768318198262
   PubMed Web of Science ®Google Scholar
• Sukys-ClaudinoLMoraesWGuilleminaultCTufikSPoyaresDBeneficial effect of donepezil on obstructive sleep apnea: a double-blind, placebo-controlled clinical trialSleep Med201213329029622281004
   PubMed Web of Science ®Google Scholar
• PearsonVEAllenRPDeanTGamaldoCELesageSREarleyCJCognitive deficits associated with restless legs syndrome (RLS)Sleep Med200671253016198145
   PubMed Web of Science ®Google Scholar
• GamaldoCEBenbrookARAllenRPOguntimeinOEarleyCJA further evaluation of the cognitive deficits associated with restless legs syndrome (RLS)Sleep Med20089550050517869573
   PubMed Web of Science ®Google Scholar
• SrinivasanVKaurCPandi-PerumalSBrownGMCardinaliDPMelatonin and its agonist ramelteon in Alzheimer’s disease: Possible therapeutic valueInt J Alzheimers Dis2010201174197421197086
   PubMedGoogle Scholar
• Pandi-PerumalSRSpenceDWVersterJCPharmacotherapy of insomnia with ramelteon: Safety, efficacy and clinical applicationsJ Cent Nerv Syst Dis20113516523861638
   PubMedGoogle Scholar
• RothTSeidenDSainatiSWang-WeigandSZhangJZeePEffects of ramelteon on patient-reported sleep latency in older adults with chronic insomniaSleep Med20067431231816709464
   PubMed Web of Science ®Google Scholar
• Guardiola-LemaitreBDe BodinatCDelagrangePMillanMJMunozCMocaerEAgomelatine: mechanism of action and pharmacological profile in relation to antidepressant propertiesBr J Pharmacol2014171153604361924724693
   PubMed Web of Science ®Google Scholar
• TaylorDSparshattAVarmaSOlofinjanaOAntidepressant efficacy of agomelatine: meta-analysis of published and unpublished studiesBMJ2014348g188824647162
   PubMed Web of Science ®Google Scholar
• DubovskySLWarrenCAgomelatine, a melatonin agonist with antidepressant propertiesExpert Opin Investig Drugs2009181015331540
   PubMed Web of Science ®Google Scholar
• SansoneRASansoneLAAgomelatine: a novel antidepressantInnov Clin Neurosci20118111014
   Google Scholar
• KasperSHajakGThe efficacy of agomelatine in previously-treated depressed patientsEur Neuropsychopharmacol201323881482123820051
   PubMed Web of Science ®Google Scholar
• MacIsaacSECarvalhoAFChaDSMansurRBMcIntyreRSThe mechanism, efficacy, and tolerability profile of agomelatineExpert Opin Pharmacother201415225927424328686
   PubMed Web of Science ®Google Scholar
• GahrMAgomelatine in the treatment of major depressive disorder: an assessment of benefits and risksCurr Neuropharmacol201412528739825426008
   PubMed Web of Science ®Google Scholar
• NeubauerDNTasimelteon for the treatment of non-24-hour sleep-wake disorderDrugs Today (Barc)2015511293525685859
   PubMed Web of Science ®Google Scholar
• EquihuaACDe La Herran-AritaAKDrucker-ColinROrexin receptor antagonists as therapeutic agents for insomniaFront Pharmacol2013416324416019
   PubMed Web of Science ®Google Scholar
• BossCOrexin receptor antagonists – a patent review (2010 to august 2014)Expert Opin Ther Pat201424121367138125407283
   PubMed Web of Science ®Google Scholar
• ChristopherJAOrexin receptor antagonistsPharm Pat Anal20121332934624236845
   PubMedGoogle Scholar
• AndrewsSPAvesSJChristopherJANonooROrexin receptor antagonists: Historical perspectives and future opportunitiesCurr Top Med Chem Epub2015929
   Web of Science ®Google Scholar
• RoeckerAJCoxCDColemanPJOrexin receptor antagonists: new therapeutic agents for the treatment of insomniaJ Med Chem Epub2015915
   Google Scholar
• MiedaMSakuraiTOrexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current statusCNS Drugs2013272839023359095
   PubMed Web of Science ®Google Scholar
• WinrowCJRengerJJDiscovery and development of orexin receptor antagonists as therapeutics for insomniaBr J Pharmacol2014171228329323731216
   PubMed Web of Science ®Google Scholar
• MichelsonDSnyderEParadisESafety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trialLancet Neurol201413546147124680372
   PubMed Web of Science ®Google Scholar
• JacobsonLHCallanderGEHoyerDSuvorexant for the treatment of insomniaExpert Rev Clin Pharmacol20147671173025318834
   PubMed Web of Science ®Google Scholar
• SunHPalczaJCardDEffects of suvorexant, an orexin receptor antagonist, on respiration during sleep in patients with obstructive sleep apneaJ Clin Sleep Med Epub2015615
   Web of Science ®Google Scholar
• HirotaTLeeJWLewisWGHigh-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIalpha as a clock regulatory kinasePLoS Biol2010812e100055921179498
   PubMed Web of Science ®Google Scholar
• ChenZYooSHParkYSIdentification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screeningProc Natl Acad Sci U S A2012109110110622184224
   PubMed Web of Science ®Google Scholar
• Gerhart-HinesZLazarMARev-erbalpha and the circadian transcriptional regulation of metabolismDiabetes Obes Metab201517Suppl 1121626332963
   PubMed Web of Science ®Google Scholar
• MehtaNChengAHChiangCKGRK2 fine-tunes circadian clock speed and entrainment via transcriptional and post-translational control of PERIOD proteinsCell Rep20151281272128826279567
   PubMed Web of Science ®Google Scholar
• PritchettDJagannathABrownLADeletion of metabotropic glutamate receptors 2 and 3 (mGlu2 and mGlu3) in mice disrupts sleep and wheel-running activity, and increases the sensitivity of the circadian system to lightPLoS One2015105e012552325950516
   PubMed Web of Science ®Google Scholar
• SerchovTJilgAWolfCTRadtkeIStehleJHHeumannRRas activity oscillates in the mouse suprachiasmatic nucleus and modulates circadian clock dynamicsMol Neurobiol Epub2015312
   Web of Science ®Google Scholar
• SoltLAWangYBanerjeeSRegulation of circadian behaviour and metabolism by synthetic REV-ERB agonistsNature20124857396626822460951
   PubMed Web of Science ®Google Scholar